Approvals/CIMA-AEMPS/LEVOSIMENDAN EVER PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Approved

STANDARD

LEVOSIMENDAN EVER PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG

Ever Valinject Gmbh🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 0f78b4cc6e7b2846
Drug Cima Aemps Name: LEVOSIMENDAN EVER PHARMA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number: 88852
Holder Company Name: Ever Valinject Gmbh
Marketing Company Name: Ever Pharma Therapeutics Spain S.L.
Authorization Date: 2023-05-22
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 2,5 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Ever Valinject Gmbh

LEVOSIMENDAN

2,5 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

May 22, 2023

Approval ID

0f78b4cc6e7b2846

Type

Standard